Funding opportunities for COVID-19 research available to investigators
Research Development and the Research Concierge Service at Penn State College of Medicine have developed a list of funding opportunities for investigators interested in research projects related to COVID-19.
The National Science Foundation, National Institutes of Health, Centers for Disease Control and other institutions are supporting research from a variety of disciplines to address the COVID-19 pandemic.
Note regarding human subjects research
In order to reduce any additional personal contact between individuals, any observational study (whether inpatient or outpatient) that requires any additional face-to-face contact with patients will not be allowed. In addition, any sample collection that requires any use of personal proactive equipment (masks, gowns, face shields, etc.) is not allowed, except as part of an interventional study with the potential for direct patient benefit.
Due to biosafety concerns, any study that aims to enroll COVID-19 subjects will require a modification to the protocol for IRB approval, which will include a biosafety review. COVID-19 patients cannot be enrolled on existing protocols without this modification approved.
COVID-19-related studies that require storing specimens must be closely coordinated with the Human Subjects Protection Office, IRB and the Department of Pathology.
See details on the University’s requirements for human subjects research here.
University funding
- Added April 7, 2020: Institute for Computational and Data Sciences’ Explore Grants – note that this opportunity focuses on supporting Penn State researchers using Penn State’s supercomputing system (ICDS-ACI), collaboration with the ICDS RISE team of computational experts and assistance accessing the rapidly growing stores of COVID-19 data beyond Penn State (rolling deadline)
Centers for Disease Control and Prevention
- Updated March 26, 2020: 75D301-20-R-67897 Centers for Disease Control COVID-19 Broad Agency Announcement Amendment 00001 (original announcement at 75D301-20-R-67897 Centers for Disease Control COVID-19 Broad Agency Announcement)
- Added March 23, 2020: CDC-RFA-OT18-18020202SUPP20 Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health – note funding is only available for the organizations that were previously awarded funding under Funding Strategy 1 of CDC-RFA-OT18-1802: “Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health,” in FY2018
Department of Agriculture (USDA)
- Added April 15, 2020: Distance Learning and Telemedicine Grants
Department of Defense
- Added April 23, 2020: Army Medical Research and Development Command New Products and Ideas (NPI)
- Added April 23, 2020: Department of the Navy Ad Hoc COVID-19 Analytics and Naval Medical Strategic Planning Process Development
- Added April 23, 2020: Joint Acquisition Task Force (JATF) COVID-19
- Added April 15, 2020: Army Applications Laboratory: COVID-19 Response Innovations
- Added April 9, 2020: Defense Logistics Agency Request for Whitepapers – Personal Protection Equipement (PPE) Re-Use and Decontamination; Prototype PPE N95 Equivalent Masks
- Added April 7, 2020: BRO-20-NEWTON Newton Award for Transformative Ideas during the COVID-19 Pandemic
- Added March 23, 2020: Medical CBRN Defense Consortium Request for Information (RFI) – CoV Pandemic Response
Department of Defense: Congressionally Directed Medical Research Programs (CDMRP)
- Added April 15, 2020: Medical Research Program Awards for Emerging Viral Diseases and Respiratory Health
Department of Defense: Defense Advanced Research Projects Agency (DARPA)
- Added March 23, 2020: HR001119S0048 Biological Technologies BAA
- Added March 23, 2020: HR001119S0071 Defense Sciences Office BAA
Resources
- Added March 23, 2020: From the agency’s COVID-19 FAQ – I have a research project idea related to COVID-19. Where should I submit my proposal? DARPA is always interested in new ideas and emerging technologies and solutions. The DARPA technical offices that are focused on these efforts are the Defense Sciences Office (DSO) and the Biological Technology Office (BTO), both of which have Office-Wide Broad Agency Announcements (BAA) that are open for the submission of new ideas at any time.
Department of Energy
- Added March 23, 2020: Department of Energy Call for Suggestions and Collaborations to address COVID-19
Resources
- Added March 23, 2020: DOE Resources Supporting Coronavirus Research
Department of Health and Human Services
- Added May 1, 2020: MP-CPI-20-006 National Infrastructure for Mitigating the Impact of COVID-19 within Racial and Ethnic Minority Communities
- Updated April 27, 2020: Biomedical Advanced Research and Development Authority (BARDA) – BAA-18-100-SOL-00003 Broad Agency Announcement (BAA) – COVID-19 – note only submissions in support of COVID-19 research are being reviewed by BARDA at this time
- Added April 23, 2020: Agency for Healthcare Research and Quality (AHRQ) – Supplemental Evidence and Data Request on Safety of Vaccines Used for Routine Immunization in the United States
- Added April 7, 2020: Substance Abuse and Mental Health Services Administration (SAMHSA) – FG-20-006 Emergency Grants to Address Mental and Substance Use Disorders During COVID-19
Department of Homeland Security: Transportation Security Administration (TSA)
- Added March 23, 2020: TSA Industry Assistance with COVID-19
Medical Technology Enterprise Consortium (MTEC)
- Added May 4, 2020: Wearable Diagnostic for Detection of COVID-19 Infection RPP
National Aeronautics and Space Administration (NASA)
- Added April 9, 2020: Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 Pandemic
National Institutes of Health (NIH)
- NEW Added Nov. 19, 2020: NOT-ES-21-002 – Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities (deadline Dec. 30, 2020; those applying must submit using PA-20-135 or PA-20-272 or their subsequent reissued equivalent)
- Added Nov. 8, 2020: NOT-AI-20-065 – Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 (deadline Sept. 1, 2021)
- Added Nov. 8, 2020: NOT-DA-20-084 – Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection (deadline Sept. 8, 2024)
- Added Oct. 26, 2020: NOT-HD-20-031 – Notice of Special Interest (NOSI): Research on Rehabilitation Needs Associated with the COVID-19 Pandemic (deadline May 8, 2023)
- Added Sept. 23, 2020: NOT-AI-20-065 – Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 (deadline Sept. 1, 2021)
- Added Sept. 23, 2020: NOT-OD-20-156: Notice of Change to Funding Announcement (NOT-OD-20-048) by the Office of Research on Women’s Health (ORWH), ” Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)” (deadline Jan. 21, 2021)
- Added Aug. 11, 2020: Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (rolling deadline and review)
- Added Aug. 3, 2020: PAR-20-256 (NIAID) – Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by “The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020” and “The Coronavirus Aid, Relief and Economic Security (CARES) Act.” (deadline July 8, 2021)
- Added July 20, 2020: RFA-DK-20-021 (NIDDK) – Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 clinical trial optional) (application deadline Dec. 16, 2020)
- Added July 20, 2020: NOT-OD-20-122 – Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
- Added July 20, 2020: RFA-DK-20-021 (NIDDK) – Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) (Special Note: NIDDK intends to commit $5 million in FY 2021 to fund 11-13 awards) (application deadline Dec. 16, 2020)
- Added July 10, 2020: PAR-20-243 – Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 – Clinical Trial Optional) (deadlines: Dec. 2, 2020, and March 2, 2021)
- Added July 10, 2020: NOT-OD-20-129 – Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project (deadlines Nov. 12, 2020, and July 12, 2021) Note: Applications for this initiative must be submitted electronically using one of the following target opportunities or their subsequent reissued equivalents: PA-18-591 or PA-18-935.
- Added July 10, 2020: NOT-AI-20-059 – NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). Applications in response to this NOSI must be submitted using the following targeted funding opportunity or subsequently reissued equivalent: PA-20-135. (deadline July 2, 2021)
- Added June 28, 2020: PAR-20-237: Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) (deadline Dec. 1, 2020)
- Added June 22, 2020: NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) (multiple deadlines through 2021)
- Updated May 19, 2020: NOT-AI-20-051 Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (deadline Sept. 8, 2021)
- Added May 4, 2020: National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network Fast-Track Program for COVID-19 Test Development and Distribution: Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing (NIBIB) (rolling deadline)
- Updated May 1, 2020: NOT-DK-20-026 Notice of Additional Activity Code Accepted for “NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK”
- Added May 1, 2020: NOT-TR-20-018 Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
- Added April 27, 2020: NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (deadline May 1, 2021)
- Added April 27, 2020: NOT-CA-20-043 Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
- Added April 27, 2020: NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19
- Added April 27, 2020: NOT-EB-20-006 Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (deadline March 31, 2021)
- Added April 27, 2020: NOT-EB-20-007 Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (deadline March 31, 2021)
- Added April 27, 2020: NOT-ES-20-015 Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (deadline May 4, 2021)
- Added April 27, 2020: NOT-ES-20-020 Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
- Added April 27, 2020: NOT-MD-20-019 Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities (deadline May 1, 2021)
- Added April 27, 2020: NOT-TR-20-017 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus (deadline Jan. 26, 2022)
- Added April 27, 2020: PA-18-591 Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (deadline Jan. 26, 2021)
- Added April 27, 2020: PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) (deadline Jan. 25, 2022)
- Added April 27, 2020: PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) (deadline March 10, 2023)
- Updated April 7, 2020: NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need (deadline July 10, 2021)
- Added March 26, 2020: NOT-GM-20-025 Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (deadline Feb. 6, 2021)
- Added March 23, 2020: NOT-DA-20-047 Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (deadline March 31, 2021)
Resources
- Added March 26, 2020: Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding – includes a video update on common questions, FAQs on flexibilities for the research community, funding opportunities and more
- Added March 23, 2020: NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
- Added March 23, 2020: NIH Fogarty International Center Coronavirus news, funding and resources for global health researchers (resource)
- Added March 23, 2020: RFA-AI-20-028 Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
National Science Foundation: RAPID Research on Coronavirus (COVID-19)
- Added March 27, 2020: NSF 20-065 Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
- Added March 23, 2020: NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) (also see NSF 20-052 FAQs)
- Added March 23, 2020: NSF 20-055 Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)
Resources
Patient-Centered Outcomes Research Institute (PCORI)
- Added April 23, 2020: PCORI Funding Opportunities for COVID-19-Related Enhancements to Existing PCORI-Funded Projects (rolling deadline)
USAID
- Added March 23, 2020: 7200AA20RFA00007 Strategies To Prevent (STOP) Spillover RFI and Virtual Conference (3.23)
Foundations
Note: Investigators with interest in foundation funding should contact Corporate and Foundation Relations before proceeding with any application process.
- Added May 19, 2020: Draper Richards Kaplan Foundation Coronavirus Urgent Response Initiative (rolling deadline)
Other Funders
Note: Investigators with interest in corporate funding should contact Corporate and Foundation Relations before proceeding with any application process.
- Added Aug. 11, 2020: Social Science Research Council – Just Tech Covid-19 Rapid-Response Grants (rolling deadline)
- Added May 15, 2020: CETF and Rockefeller Philanthropy Advisors – COVID-19 Early Treatment Fund (rolling deadline)
- Added April 27, 2020: EdTech Hub, mEducation Alliance and Global Innovation Exchange Call for Ideas for EdTech Responses to Coronavirus (COVID-19) (rolling deadline)
- Added April 27, 2020: Rapidly Emerging Antiviral Drug Discovery Initiative (READDI)
- Added April 15, 2020: Allen Institute for AI COVID-19 Open Research Dataset Challenge (CORD-19)
- Added April 15, 2020: CoVent-19 Challenge: Innovate2Ventilate
- Added April 15, 2020: IBM: COVID-19 Call for Code
- Added April 15, 2020: XPRIZE Pandemic Alliance: Fight COVID-19
- Added April 13, 2020: Google Cloud Research Credits
- Added April 9, 2020: Emergent Ventures: Fast Funding for COVID-19 Science
- Added April 9, 2020: Joint European Disruptive Initiative (JEDI) – Billion Molecules Against COVID-19 JEDI Grand Challenge
- Added April 8, 2020: Pfizer COVID-19-Related Grant Requests
- Added March 26, 2020: Amazon AWS Diagnostic Development Initiative (DDI)
Learn more
For details, contact the Research Concierge Service at researchconcierge@pennstatehealth.psu.edu.
If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.